The move to introduce cabotegravir injections brings Northern Ireland into line with the rest of Great Britain.

For the last several quarters, Gilead Sciences’ earnings calls have been colored by anticipation for the launch of the California drugmaker's long-acting HIV pre-exposure prophylaxis (PrEP) option. | ...

Oral HIV pre-exposure prophylaxis (PrEP) adoption varies across the US, with posters presented at the Academy of Managed Care Pharmacy Nexus 2025 meeting in National Harbor, Maryland, highlighting ...

PrEP is a crucial tool in the fight against the ongoing HIV epidemic, but systemic factors pose major barriers to access for Black women. Alexis Perkins thought her OB-GYN’s office in Atlanta would be ...

More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...

Please provide your email address to receive an email when new articles are posted on . PrEP coverage in the U.S. between 2012-2021 ranged from 3.8% in West Virginia to 22.2% in New York. Australian ...

Anne Neilan, MD, a physician-scientist in the division of Infectious Diseases at Massachusetts General Hospital is the senior author of a recently published paper in Clinical Infectious Diseases, ...

A little specificity would go a long way in the recommendations of the US Preventive Services Task Force (USPSTF)—that is, if we want health insurance companies to pay for lifesaving HIV prevention ...

This content is sponsored by MedStar Washington Hospital Center. The Centers for Disease Control and Prevention (CDC) estimates that 1.2 million people in the U.S. had HIV at the end of 2021. Although ...

In May, just before Pride Month, the Centers for Disease Control and Prevention released news worth celebrating: 2021 saw the lowest numbers of new HIV diagnoses in decades. New HIV infections were ...